8,816 Shares in Amedisys, Inc. (NASDAQ:AMED) Purchased by Teacher Retirement System of Texas

Teacher Retirement System of Texas purchased a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 8,816 shares of the health services provider's stock, valued at approximately $817,000.

Several other hedge funds also recently made changes to their positions in AMED. Norges Bank purchased a new position in shares of Amedisys in the fourth quarter worth $83,061,000. Pentwater Capital Management LP increased its stake in shares of Amedisys by 178.3% in the fourth quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider's stock worth $107,132,000 after buying an additional 756,000 shares during the period. AQR Arbitrage LLC increased its stake in shares of Amedisys by 59.1% in the fourth quarter. AQR Arbitrage LLC now owns 471,965 shares of the health services provider's stock worth $42,812,000 after buying an additional 175,311 shares during the period. Birnam Oak Advisors LP purchased a new position in shares of Amedisys in the fourth quarter worth $15,832,000. Finally, Toronto Dominion Bank purchased a new position in Amedisys during the 4th quarter valued at $15,801,000. 94.36% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Wall Street Zen downgraded shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research report on Saturday, May 24th. Royal Bank Of Canada reissued an "outperform" rating and set a $100.00 price objective on shares of Amedisys in a research report on Wednesday, April 16th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Amedisys presently has a consensus rating of "Hold" and a consensus price target of $100.75.

Amedisys Stock Down 0.0%

Shares of AMED stock traded down $0.03 during mid-day trading on Wednesday, reaching $97.48. 270,033 shares of the company's stock traded hands, compared to its average volume of 413,947. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95. The company has a market cap of $3.20 billion, a P/E ratio of 35.97, a P/E/G ratio of 1.32 and a beta of 0.94. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.27. The company's 50-day moving average price is $95.92 and its 200-day moving average price is $93.64.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. Amedisys had a net margin of 3.79% and a return on equity of 12.52%. The firm had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. During the same quarter in the previous year, the business posted $1.03 EPS. The company's quarterly revenue was up 4.1% on a year-over-year basis. On average, equities analysts expect that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.